Mortality Rate was unsightly!!! 4/24/2013. Sepsis Quality Improvement Project

Similar documents
Diagnosis: Allergies:

Severe β-lactam allergy. Alternative (use for mild-moderate β-lactam allergy) therapy

Guidebook for ED and Inpatient Sepsis Order Set Initiatives 2018

AnnMarie Papa, DNP,RN,CEN,NE-BC,FAEN, FAAN Clinical Director, Emergency, Medical & Observation Nursing Hospital of the University of Pennsylvania

December 3, 2015 Severe Sepsis and Septic Shock Antibiotic Guide

DRUG ALLERGIES WT: KG

Staging Sepsis for the Emergency Department: Physician

DRUG ALLERGIES WT: KG

Septic Shock. Kathryn Sims, PGY I

Core Measures SEPSIS UPDATES

Dilemmas in Septic Shock

Physician's Core Measure Pocket Guide AMI

Sepsis new definitions of sepsis and septic shock and Novelities in sepsis treatment

Immunomodulation and Sepsis in Oncological Patients. Imad Haddad, M.D. Medical Director, PICU Banner Children s Hospital at BDMC

Sepsis Story At Intermountain Healthcare Intensive Medicine Clinical Program

Care Guideline DRAFT for review cycle 08/02/17 CARE OF THE ADULT PNEUMONIA PATIENT

Surviving Sepsis Campaign Guidelines 2012 & Update for David E. Tannehill, DO Critical Care Medicine Mercy Hospital St.

Saving Lives: Focusing on Severe Sepsis and Septic Shock

Patient Safety Safe Table Webcast: Sepsis (Part III and IV) December 17, 2014

Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016

Objectives. Management of Septic Shock. Definitions Progression of sepsis. Epidemiology of severe sepsis. Major goals of therapy

Sepsis: Identification and Management in an Acute Care Setting

PHYSIOLOGY AND MANAGEMENT OF THE SEPTIC PATIENT

CARE OF THE ADULT PNEUMONIA PATIENT

PHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG

John Park, MD Assistant Professor of Medicine

Critical Care Treatment Guidelines

Sepsis Early Recognition and Management. Therese Hughes, PhD, MPA, RN

Initial Resuscitation of Sepsis & Septic Shock

MONTEFIORE MEDICAL CENTER

Printed copies of this document may not be up to date, obtain the most recent version from

INTENSIVE CARE MEDICINE CPD EVENING. Dr Alastair Morgan Wednesday 13 th September 2017

EFFECT OF EARLY VASOPRESSIN VS NOREPINEPHRINE ON KIDNEY FAILURE IN PATIENTS WITH SEPTIC SHOCK. Alexandria Rydz

Physician Orders ADULT Order Set: Respiratory Failure Orders

CARE PATHWAY FOR CHILDREN AND YOUNG PERSONS WITH FEBRILE NEUTROPENIA, NEUTROPENIC SEPSIS OR SUSPECTED CENTRAL VENOUS LINE INFECTIONS

Session 1: Circuit, Anticoagulation and Monitoring. Ashita Tolwani, MD, MSc Noel Oabel, BSN, RN, CNN 2019

Sepsis Update Allina Critical Care Conference February 28, 2018

Surviving Sepsis: A CRASH Course. Justin Jones, PharmD Sanford Medical Center, Fargo Staff Education 2015

Sepsis. From EMS to ER to ICU. What we need to be doing

Septic Shock. Rontgene M. Solante, MD, FPCP,FPSMID

The Septic Patient. Dr Arunraj Navaratnarajah. Renal SpR Imperial College NHS Healthcare Trust

Sepsis overview. Dr. Tsang Hin Hung MBBS FHKCP FRCP

Potential Conflicts of Interests

Osteomyelitis Samir S. Shah, MD, MSCE

Frank Sebat, MD - June 29, 2006

Sepsis Management: Past, Present, and Future

Inpatient Quality Reporting Program

Organ Donor Management Recommended Guidelines ADULT CARDIAC DEATH (DCD)

The Ever Changing World of Sepsis Management. Laura Evans MD MSc Medical Director of Critical Care Bellevue Hospital

Early Goal-Directed Therapy

Evaluation of Vancomycin Continuous Infusion in Trauma Patients

Neutropenic Fever 1 InpatientPediatric Treatment

Organ Donor Management Recommended Guidelines ADULT Brain Death (NDD)

Updates On Sepsis Updates based on 2016 updates on sepsis from The International Surviving Sepsis Campaign

Inpatient Quality Reporting Program

The syndrome formerly known as. Severe Sepsis. James Rooks MD. Coordinator of critical care education OU College of Medicine, Tulsa

Sepsis is an important issue. Clinician s decision-making capability. Guideline recommendations

Sepsis - A Year in Transition

Sepsis 3 & Early Identification. Disclosures. Objectives 9/19/2016. David Carlbom, MD Medical Director, HMC Sepsis Program

Controversies in Hospital Medicine: Critical Care. Vasopressors, Steroids, and Insulin Therapy

Sepsis Care and the New Core Measures. Daniel S. Hagg, MD January 15, 2016

PEDIATRIC LIFEGIFT BRAIN DEATH PLAN

9/25/2017. Nothing to disclose

Nothing to disclose 9/25/2017

Septic shock. Babak Tamizi Far M.D Isfahan university of medical sciences

Sepsis Management Update 2014

Fluid Resuscitation and Monitoring in Sepsis. Deepa Gotur, MD, FCCP Anne Rain T. Brown, PharmD, BCPS

No conflicts of interest to disclose

Neutropenic Fever. CID 2011; 52 (4):e56-e93

FLUID RESUSCITATION AND MONITORING IN SEPSIS PROTOCOLIZED VS USUAL CARE DEEPA BANGALORE GOTUR MD, FCCP ASSISTANT PROFESSOR, WEILL CORNELL MEDICAL

Standardize comprehensive care of the patient with severe traumatic brain injury

Sepsis care and the new core measures

Guidelines are the Future of Sepsis Management Pro

Evidence-Based. Management of Severe Sepsis. What is the BP Target?

R2R: Severe sepsis/septic shock. Surat Tongyoo Critical care medicine Siriraj Hospital

Sepsis Awareness and Education

Sepsis or Severe Sepsis? Is there a right thing, and how do we do it?

Early Goal Directed Therapy in 2015: What Did the Big Trials Teach us?

Sepsis Update: Focus on Early Recognition and Intervention. Disclosures

BC Sepsis Network Emergency Department Sepsis Guidelines

Surviving Sepsis. Brian Woodcock MBChB MRCP FRCA FCCM

Adult Inpatient Antibiogram. Antimicrobial Susceptibilities of Frequently Recovered Clinical Isolates. January to December 2016

Update in Sepsis. Conflicts of Interest: None. Bill Janssen, M.D.

Surviving Sepsis Campaign

** Medication exercises ** NICU Phase II

SEPSIS PLAN - Phase:.

DKA Adult ICU Powerplan

DIAGNOSIS CRITERIA RECOMMENDATIONS FOR CRITERIA

Objectives. Epidemiology of Sepsis. Review Guidelines for Resuscitation. Tx: EGDT, timing/choice of abx, activated

LIFEGIFT BRAIN DEATH PLAN

PHYSICIAN S ORDERS Page 1 of 5 PNEUMONIA. Resuscitation (Code)Status: Admit to: Diagnosis: Pneumonia Other: Consult:

2016 Sepsis Update: Pearls, Pitfalls, and Core Measure Quicksand

Updates in Sepsis 2017

MAKING SENSE OF IT ALL AUGUST 17

Daptomycin in Clinical Practice. Paolo Grossi

Prospective audit and feedback of piperacillin-tazobactam use in a 1115 bed acute care hospital

SARASOTA MEMORIAL HOSPITAL DEPARTMENT POLICY

Neutropenic Fever 1 InpatientPediatric Treatment

Emergency Department Guideline. Anaphylaxis

Transcription:

Libby, MT Sepsis Quality Improvement Project Barb Dumont RN, Director of Quality and Risk Management Mike Julius RN, ED Manager Cathy Wolfe RN, Chief Nursing Officer. Mortality Rate was unsightly!!! percent Mortality Rate 100% 80% 60% 40% 20% 0% Discharge Status Alive 52.9% Transferred 11.8% Deceased 35.3% 1

Our Emergency Physician Team 2

Mike Julius, RN, ED Manager Dr. Raymond Zurcher, Emergency Physician Nursing Physicians Pharmacy Respiratory Laboratory Everyone 3

Up grade equipment that allows for invasive monitoring in ED and ICU Develop pre printed orders everyone on the same page Aggressive and early antibiotic therapy initiated Maintain SVO2 > or equal 70% Continued Quality Improvement through Emergency Medicine Committee Up graded our telemetry and monitoring (with Mindray) 4

Developed Approved by all committees Crossed over and implemented them in electronic documentation in Meditech Use the paper tool during down time Review Sepsis Orders Check for Antibiotics that appropriate Continue with our process improvement 5

First Draft Reviewed by nursing staff and physician staff. REMINDER: All orders must be dated, timed, and signed by the prescribing physician. ORDERS AND SIGNATURE 1. If Lactic acid greater than recheck Lactic Acid every hours X 2. If Lactic Acid greater than 4: central line placement and monitor ScvO 2 3. INITIAL FLUID RESUSCITATION minimum 30 ml/kg bolus recommended Pt wt: kg X 30 ml/kg = ml for initial bolus. NS 1000 ml over 30 60 minutes and repeat bolus of NS 500ml until 30ml/kg met. Repeat Lactic Acid one hour after initial 30ml/kg bolus and every 4 hours X 4. Continue boluses of NS 500ml X for target CVP of greater than 8 mm Hg (greater than 12 mm Hg if mechanically ventilated) and/or MAP greater than 65 mm Hg. If unable to meet parameters contact physician for further fluid orders. 4. ANTIBIOTICS Administer the following antibiotics within 3 hours of presentation (see page two for recommendations) STAT antibiotic # 1 STAT antibiotic # 2 For meningitis: give Decadron 10 mg IV 20 minutes prior to antibiotics Goals for first six hours of resuscitation: CENTRAL LINE PLACEMENT TO ACHIEVE THE FOLLOWING CVP 8 12 mm Hg (Greater than 12 is goal if on mechanical ventilation) MAP > 65 mm Hg ScvO2 > 70% (draw sample from central line) 5. HEMODYNAMIC/TISSUE PERFUSION MONITORIN: Monitor and document CVP, MAP, and ScvO 2 every 30 minutes 6. VASOPRESSORS: Consider vasopressors if patient remains hypotensive after 30 ml/kg fluid resuscitation Norepinephrine is first choice in sever sepsis. 7. ADDITIONAL SUPPORTIVE THERAPY: If ScvO 2 remains less than 70% despite a CVP of 8 12 mm Hg non-intubated (or 12 15 mm Hg if mechanically ventilated) and the addition of vasopressors consider: Transfusion Therapy: 1 unit packed red cells if Hgb less than 7 mg/dl Inotropic Therapy: DOBUTAMINE Start IV infusion at 2.5 mcg/kg/min and may titrate by 2.5 mcg/kg/min every 10 minutes to maintain ScvO 2 > 70%. Maximum dose is 40 mcg/kg/min. 8. GLUCOSE CONTROL (Goal blood glucose: 120 170 mg/ml) Finger-stick blood stick every 4 hours Initiate IV insulin drip order set (non-dka) if glucose greater than 180 mg/dl 9. Other orders Date: Time: Physician Signature P a g e 1 6

ANTI-INFECTIVE EMPERIC THERAPY Culture should be obtained prior to administration Administer antibiotics within the first hour of recognition of severe sepsis, initiate in ER Consider combination therapy in neutropenic patients or those with Pseudomonal infections Once cultures and sensitivity have been reported begin transporting from empiric broad spectrum antibiotics to more specific antibiotic drug regimens. Reassess anti-infective regimen daily to optimize efficacy, prevent resistance, avoid toxicity, and minimize costs. Duration of therapy is 14 days (bloodstream) or 10 days (non-bloodstream): longer durations may be necessary in certain situations (i.e. endocarditis/osteomyellitis). Consider stopping anti-infective therapy if cause is found to be non-infectious. Pharmacy to renal dose adjusts medications as needed per protocol. Select anti-infective empiric regimen based on probable site of infection below: 1. Intra-abdominal Zosyn 3.375 gm IV every six hours (consider renal dosing) or Tigecycline 100mg IV x 1dose then 50 mg IV every 12 hours. 2. Skin/soft tissue infection Vancomycin 1 gm IV every 12 hours. Adjust dose for goal trough levels between 10 15, or Linezolid 600 mg IV every 12 hours If necrotizing infection add Zosyn 3.375 gm IV every six hours (consider renal dosing) 3. Central Line Infection: Line removal plus antibiotic therapy If MRSA suspected: Vancomycin 1 gm IV every 12 hours. Adjust dose for goal trough levels between 10 15, or Daptomycin 6 mg/kg IV every 24 hours or Linezolid 600 mg IV every 12 hours If non-mrsa (empiric therapy) Cefepime 2 gm IV every 12 hours or if PCN allergy may give Levofloxacin 750 mg IV every 24 hours (consider renal dosing) 4. Lungs (Healthcare Associated Pneumonia) Zosyn 4.5 gm IV every six hours (consider renal dosing) and Gentamycin 7 mg/kg IV every 24 hours If PCN allergy may give : Aztreonam 2 gm IV every 6 hours and Gentamycin 7 mg/kg IV every 24 hours If MRSA is suspected add to either regimen: Linezolid 600 mg IV every 12 hours or Vancomycin 1 gm IV every 12 hours, adjust dose for goal trough levels between 15 and 20. 5. Lungs (Community Acquired Pneumonia) Ceftriaxone 2 gm IV every 24 hours and Azithromycin 500 mg every 24 hours. If PCN allergy: may give Levofloxacin 750 mg IV every 24 hours (consider renal dosing) and Aztreonam 2 gm IV every 6 hours. If MRSA is suspected add to either regimen: Linezolid 600 mg IV every 12 hours or Vancomycin 1 gm IV every 12 hours, adjust dose for renal trough levels between 15 20. 6. Urosepsis Zosyn 3.375 gm IV every 6 hours (consider renal dosing) If PCN allergy: may give Levofloxacin 750 mg IV every 24 hours (consider renal dosing) If VRE suspected give: Linezolid 600 mg IV every 12 hours. 7. Sepsis with Purpura (asplenia or hyposplenia) Ceftriaxone 2 gm IV every 24 hours or Levofloxacin 500 mg IV every 24 hours (consider renal dosing) 8. Sepsis secondary to chronic high dose steroids (Aspergillus Pneumonia) Voriconazole 6 mg/kg IV every 12 hours X 2 doses, then 3 mg/kg IV every 12 hours (consider renal dosing) or Micafungin 100 mg IV every 24 hours (preferred when CrCl < 50 ml/min 9. Persistent Fever and neutropenia after 5 days of empiric antibacterial therapy Micafungin 100 mg IV every 24 hours or Voriconazole 6 mg/kg IV every 12 hours X 2 doses, then 3 mg/kg IV every 12 hours. 10. Unknown site Vancomycin 1 gm IV every 12 hours. Adjust dose for trough levels between 15 20 and Zosyn 3.375 gm IV every 6 hours (consider renal dosing) and Gentamycin 7 mg/kg IV every 24 hours. P a g e 2 P a g e 1 7

This image cannot currently be displayed. 4/24/2013 P a g e 2 Our ED Manager manages and views the process Brings to Committee 8

We improved Input the data (have the numbers) 100% Mortality Rate 80% percent 60% 40% 20% 0% Discharge Status Alive 2011 52.9% Alive 2012 57.1% Transferred 2011 11.8% Transferred 2012 33.3% Deceased 2011 35.3% Deceased 2012 9.5% 9